These tests will foster the detection rate of early cancer in patients – providing not only a far less invasive examination as compared to the conventional scope method, but also give patients a cheap, convenient and safe alternative.
Published by Blackwell Publishing, this study appears in the February 2007 issue of the newly re-named Journal of Digestive Diseases – the official journal of the Chinese Society of Gastroenterology.
As the second leading cause of cancer-related deaths worldwide, endoscopy and biopsy have been the conventional methods employed for the screening and diagnosis of gastric cancer and atrophic gastritis. After evaluating the risk of atrophic gastritis and gastric cancer with serological tests, researchers have concluded that serum pepsinogen, gastrin-17 and Helicobacter pylori IgG antibodies can be employed effectually to screen for atrophic gastritis and gastric cancer.
Leading author Dr. Cao Qin, Instructor of Medicine at the Shanghai Jiaotong University School of Medicine affiliated Renji Hospital, said “In Shanghai the age-standardized incidence of gastric cancer in men has been halved over the last 30 years, from 62 in every 100,000 in 1972, to just 29 out of every 100,000 in 2002. While the incidence and mortality rates have fallen dramatically in many regions - including countries like the United States, France, and Switzerland – other regions such as Shanghai remain a high risk area. With serum tests now enabling an even earlier detection of atrophic gastritis and gastric cancer, we hope this positive trend can be further improved on.”
Dr. Cao added, “Serological tests are an extremely efficient method of detecting the risk of atrophic gastritis and gastric cancer – our evaluations indicate that these serum tests can be used in large scale populations because of its obvious cost and saving advantages.”
This paper is published in the February 2007 issue of the newly renamed Journal of Digestive Diseases. Media wishing to receive the PDF study of the research paper or to interview the authors should contact Alina Boey, Public Relations Asia.
About Journal of Digestive Diseases
Journal of Digestive Diseases serves the dual purpose of allowing Chinese researchers to communicate their results to their international colleagues, and allowing non-Chinese speaking researchers to access the vital work being undertaken in China which contributes to clinical advancements throughout the region. It is the official English-language journal of the Chinese Society of Gastroenterology. The Journal is published four times per year and includes peer-reviewed original papers, review articles and commentaries concerned with research relating to the esophagus, stomach, small intestine, colon, liver, biliary tract and pancreas. The Journal also occasionally republishes, with permission, peer-reviewed articles of scientific or clinical excellence that have appeared in Chinese-language journals.
About Blackwell Publishing
Blackwell Publishing is the world’s leading society publisher, partnering with 665 medical, academic, and professional societies. Blackwell publishes over 800 journals and has over 6,000 books in print. The company employs over 1,000 staff members in offices in the US, UK, Australia, China, Singapore, Denmark, Germany, and Japan. Blackwell’s mission as an expert publisher is to create long-term partnerships with our clients that enhance learning, disseminate research, and improve the quality of professional practice.